What did @bottleneck_loser actually say?
The creator ran through nine tips for people starting feminizing hormone therapy, mixing real physiological points with humor and some claims that range from oversimplified to flat-out unsupported. The most medically relevant ones: fat redistribution requires weight gain, sexual orientation may shift, genital function is "use it or lose it," feet and hands shrink, emotions intensify, and the whole process is essentially "a second puberty."
To be fair, some of this is grounded in real biology. Others, including the claim that you "will start to want to give birth" and the bit about Magic the Gathering being ancestral trans knowledge, are either anecdotal, humorous, or belong in a completely different category. The problem is that when medical and non-medical claims live in the same list, people don't always know which is which.
Does the science back this up?
The fat redistribution claim is mostly right but meaningfully incomplete. The "use it or lose it" warning about erectile function has solid clinical backing. The emotional intensity point is supported. The feet-shrinking claim is real but modest and inconsistent. The orientation-shift point is documented but overstated.
On fat redistribution: estrogen does direct new fat storage toward the hips, thighs, and breasts, but calling it strictly "new fat in different areas" misses the nuance. Lipid mobilization and redistribution of existing fat does occur, though it is slower and less dramatic than new deposition. Klaver et al. (2018, Journal of Clinical Endocrinology and Metabolism) found both processes happen, but their relative contribution depends on the individual and the duration of therapy.
On sexual orientation: Auer et al. (2014, Journal of Sexual Medicine) documented shifts in reported sexual attraction in a subset of trans women on estrogen, but "a lot of trans women" is doing a lot of work here. Orientation changes are reported by some, not most. Presenting it as a common side effect conflates sociological and psychological complexity with pharmacology.
On the "use it or lose it" point for genital function: Wierckx et al. (2014, Journal of Sexual Medicine) and clinical guidance from WPATH Standards of Care both support the idea that penile atrophy and loss of erectile function are real risks without maintenance, particularly as testosterone suppression deepens. This one is accurate.
What did they get wrong (or right)?
The biggest factual problem is the claim that "you will start to want to give birth." Estrogen and progesterone do not create a desire for pregnancy. That framing conflates hormonal mood and emotional changes with a specific reproductive drive that has no physiological basis in people without a uterus. It is not a documented clinical effect. It may reflect personal emotional experience, but stating it as a pharmacological outcome is inaccurate.
The feet and hands claim is real but modest. Some trans women report mild edema reduction and soft tissue changes that can alter shoe size slightly, but this is not universal and no robust controlled study confirms consistent foot-size reduction as a discrete estrogen effect. Anecdote does not equal side effect.
What they got right: the "second puberty" framing is actually a useful and reasonably accurate analogy. Rosenthal (2021, Pediatric Clinics of North America) has used similar language clinically. Sleep, nutrition, and exercise do meaningfully affect outcomes during feminizing HRT, particularly for bone density and body composition. That is good, practical advice.
What should you actually know?
If you are considering or currently on feminizing HRT, here is what the evidence actually supports. Fat redistribution is real but gradual, and individual variation is significant. Genital atrophy is a legitimate concern that clinicians address, and you should raise it with your provider, not manage it based on a TikTok tip. Emotional changes in the early weeks are well-documented and worth preparing for.
Sexual orientation is a separate and complex topic. Some people do report shifts, but estrogen does not "cause" attraction changes the way it causes breast development. Treating it as a predictable pharmacological side effect misrepresents both the science and the lived diversity of trans experiences.
The "second puberty" framing is useful for setting expectations: changes are slow, they take years, and general health behaviors matter. But puberty analogies have limits. You are not a teenager, your hormonal milieu is managed rather than endogenous, and your provider should be calibrating your labs, not TikTok comment sections.
Finally, the hygiene products tip and the Magic the Gathering bit are not medical claims. One is a kind community gesture. The other is a joke. Both are fine. But mixing them into a list with actual pharmacological effects is how misinformation spreads, even when no harm is intended.